Global Human Hepatitis B Immunoglobulin (IM) Market Research Report 2017

Global Human Hepatitis B Immunoglobulin (IM) Market Research Report 2017

1 Human Hepatitis B Immunoglobulin (IM) Market Overview

1.1 Product Overview and Scope of Human Hepatitis B Immunoglobulin (IM)

1.2 Human Hepatitis B Immunoglobulin (IM) Segment by Type (Product Category)

1.2.1 Global Human Hepatitis B Immunoglobulin (IM) Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)

1.2.2 Global Human Hepatitis B Immunoglobulin (IM) Production Market Share by Type (Product Category) in 2016

1.2.3 100IU/Bottle Human Hepatitis B Immunoglobulin (IM)

1.2.4 200IU/Bottle Human Hepatitis B Immunoglobulin (IM)

1.2.5 400IU/Bottle Human Hepatitis B Immunoglobulin (IM)

1.3 Global Human Hepatitis B Immunoglobulin (IM) Segment by Application

1.3.1 Human Hepatitis B Immunoglobulin (IM) Consumption (Sales) Comparison by Application (2012-2022)

1.3.2 Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg)

1.3.3 Unexpected Crowd of Hepatitis B Infection

1.3.4 Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers

1.4 Global Human Hepatitis B Immunoglobulin (IM) Market by Region (2012-2022)

1.4.1 Global Human Hepatitis B Immunoglobulin (IM) Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)

1.4.2 North America Status and Prospect (2012-2022)

1.4.3 Europe Status and Prospect (2012-2022)

1.4.4 China Status and Prospect (2012-2022)

1.4.5 Japan Status and Prospect (2012-2022)

1.4.6 Southeast Asia Status and Prospect (2012-2022)

1.4.7 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value) of Human Hepatitis B Immunoglobulin (IM) (2012-2022)

1.5.1 Global Human Hepatitis B Immunoglobulin (IM) Revenue Status and Outlook (2012-2022)

1.5.2 Global Human Hepatitis B Immunoglobulin (IM) Capacity, Production Status and Outlook (2012-2022)

2 Global Human Hepatitis B Immunoglobulin (IM) Market Competition by Manufacturers

2.1 Global Human Hepatitis B Immunoglobulin (IM) Capacity, Production and Share by Manufacturers (2012-2017)

2.1.1 Global Human Hepatitis B Immunoglobulin (IM) Capacity and Share by Manufacturers (2012-2017)

2.1.2 Global Human Hepatitis B Immunoglobulin (IM) Production and Share by Manufacturers (2012-2017)

2.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue and Share by Manufacturers (2012-2017)

2.3 Global Human Hepatitis B Immunoglobulin (IM) Average Price by Manufacturers (2012-2017)

2.4 Manufacturers Human Hepatitis B Immunoglobulin (IM) Manufacturing Base Distribution, Sales Area and Product Type

2.5 Human Hepatitis B Immunoglobulin (IM) Market Competitive Situation and Trends

2.5.1 Human Hepatitis B Immunoglobulin (IM) Market Concentration Rate

2.5.2 Human Hepatitis B Immunoglobulin (IM) Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue (Value) by Region (2012-2017)

3.1 Global Human Hepatitis B Immunoglobulin (IM) Capacity and Market Share by Region (2012-2017)

3.2 Global Human Hepatitis B Immunoglobulin (IM) Production and Market Share by Region (2012-2017)

3.3 Global Human Hepatitis B Immunoglobulin (IM) Revenue (Value) and Market Share by Region (2012-2017)

3.4 Global Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.5 North America Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.6 Europe Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.7 China Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.8 Japan Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.9 Southeast Asia Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.10 India Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Human Hepatitis B Immunoglobulin (IM) Supply (Production), Consumption, Export, Import by Region (2012-2017)

4.1 Global Human Hepatitis B Immunoglobulin (IM) Consumption by Region (2012-2017)

4.2 North America Human Hepatitis B Immunoglobulin (IM) Production, Consumption, Export, Import (2012-2017)

4.3 Europe Human Hepatitis B Immunoglobulin (IM) Production, Consumption, Export, Import (2012-2017)

4.4 China Human Hepatitis B Immunoglobulin (IM) Production, Consumption, Export, Import (2012-2017)

4.5 Japan Human Hepatitis B Immunoglobulin (IM) Production, Consumption, Export, Import (2012-2017)

4.6 Southeast Asia Human Hepatitis B Immunoglobulin (IM) Production, Consumption, Export, Import (2012-2017)

4.7 India Human Hepatitis B Immunoglobulin (IM) Production, Consumption, Export, Import (2012-2017)

5 Global Human Hepatitis B Immunoglobulin (IM) Production, Revenue (Value), Price Trend by Type

5.1 Global Human Hepatitis B Immunoglobulin (IM) Production and Market Share by Type (2012-2017)

5.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue and Market Share by Type (2012-2017)

5.3 Global Human Hepatitis B Immunoglobulin (IM) Price by Type (2012-2017)

5.4 Global Human Hepatitis B Immunoglobulin (IM) Production Growth by Type (2012-2017)

6 Global Human Hepatitis B Immunoglobulin (IM) Market Analysis by Application

6.1 Global Human Hepatitis B Immunoglobulin (IM) Consumption and Market Share by Application (2012-2017)

6.2 Global Human Hepatitis B Immunoglobulin (IM) Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Human Hepatitis B Immunoglobulin (IM) Manufacturers Profiles/Analysis

7.1 Baxter

7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.1.2 Human Hepatitis B Immunoglobulin (IM) Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 Baxter Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.1.4 Main Business/Business Overview

7.2 CSL

7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.2.2 Human Hepatitis B Immunoglobulin (IM) Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 CSL Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.2.4 Main Business/Business Overview

7.3 Bayer

7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.3.2 Human Hepatitis B Immunoglobulin (IM) Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 Bayer Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.3.4 Main Business/Business Overview

7.4 Grifols

7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.4.2 Human Hepatitis B Immunoglobulin (IM) Product Category, Application and Specification

7.4.2.1 Product A

7.4.2.2 Product B

7.4.3 Grifols Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.4.4 Main Business/Business Overview

7.5 Octapharma

7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.5.2 Human Hepatitis B Immunoglobulin (IM) Product Category, Application and Specification

7.5.2.1 Product A

7.5.2.2 Product B

7.5.3 Octapharma Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.5.4 Main Business/Business Overview

7.6 Shanghai RAAS

7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.6.2 Human Hepatitis B Immunoglobulin (IM) Product Category, Application and Specification

7.6.2.1 Product A

7.6.2.2 Product B

7.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.6.4 Main Business/Business Overview

7.7 Hualan Biological

7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.7.2 Human Hepatitis B Immunoglobulin (IM) Product Category, Application and Specification

7.7.2.1 Product A

7.7.2.2 Product B

7.7.3 Hualan Biological Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.7.4 Main Business/Business Overview

7.8 China Biologic

7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.8.2 Human Hepatitis B Immunoglobulin (IM) Product Category, Application and Specification

7.8.2.1 Product A

7.8.2.2 Product B

7.8.3 China Biologic Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.8.4 Main Business/Business Overview

7.9 Tiantan Biologic

7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.9.2 Human Hepatitis B Immunoglobulin (IM) Product Category, Application and Specification

7.9.2.1 Product A

7.9.2.2 Product B

7.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.9.4 Main Business/Business Overview

7.10 Shuanglin Bio-pharmacy

7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.10.2 Human Hepatitis B Immunoglobulin (IM) Product Category, Application and Specification

7.10.2.1 Product A

7.10.2.2 Product B

7.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.10.4 Main Business/Business Overview

7.11 Sichuan Yuanda Shuyang

7.12 Boya Bio-pharmaceutical

7.13 Shanghai Institute of Biological

8 Human Hepatitis B Immunoglobulin (IM) Manufacturing Cost Analysis

8.1 Human Hepatitis B Immunoglobulin (IM) Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin (IM)

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Human Hepatitis B Immunoglobulin (IM) Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Human Hepatitis B Immunoglobulin (IM) Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Human Hepatitis B Immunoglobulin (IM) Market Forecast (2017-2022)

12.1 Global Human Hepatitis B Immunoglobulin (IM) Capacity, Production, Revenue Forecast (2017-2022)

12.1.1 Global Human Hepatitis B Immunoglobulin (IM) Capacity, Production and Growth Rate Forecast (2017-2022)

12.1.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue and Growth Rate Forecast (2017-2022)

12.1.3 Global Human Hepatitis B Immunoglobulin (IM) Price and Trend Forecast (2017-2022)

12.2 Global Human Hepatitis B Immunoglobulin (IM) Production, Consumption , Import and Export Forecast by Region (2017-2022)

12.2.1 North America Human Hepatitis B Immunoglobulin (IM) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.2 Europe Human Hepatitis B Immunoglobulin (IM) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.3 China Human Hepatitis B Immunoglobulin (IM) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.4 Japan Human Hepatitis B Immunoglobulin (IM) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.5 Southeast Asia Human Hepatitis B Immunoglobulin (IM) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.6 India Human Hepatitis B Immunoglobulin (IM) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.3 Global Human Hepatitis B Immunoglobulin (IM) Production, Revenue and Price Forecast by Type (2017-2022)

12.4 Global Human Hepatitis B Immunoglobulin (IM) Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer